Table 3.

Cancers Selected as Cases^a Among Elderly US Medicare Beneficiaries (n = 1,176,950), 1992–2005

Cancer Siteb	Count	% of Total
Lip	2,432	0.21
Tongue	4,619	0.39
Salivary gland	2,593	0.22
Floor of mouth	1,436	0.12
Gum and other mouth	3,907	0.33
Nasopharynx	797	0.07
Tonsil	1,620	0.14
Oropharynx	564	0.05
Hypopharynx	1,696	0.14
Other oral cavity and pharynx	527	0.04
Esophagus	11,829	1.01
Stomach	23,604	2.01
Small intestine	3,825	0.32
Cecum	29,916	2.54
Appendix	711	0.06
Ascending colon	21,333	1.81
Hepatic flexure	6,802	0.58
Transverse colon	10,617	0.90
Splenic flexure	4,122	0.35
Descending colon	6,378	0.54
Sigmoid colon	31,576	2.68
Large intestine NOS	5,946	0.51
Rectosigmoid junction	12,113	1.03
Rectum	25,555	2.17
Anus, anal canal, and anorectum	2,717	0.23
Liver	10,662	0.91
Intrahepatic bile duct	2,058	0.17
Gallbladder	3,885	0.33
Other biliary	5,102	0.43
Pancreas	34,402	2.92
Retroperitoneum	791	0.07
Peritoneum, omentum, and mesentery	1,482	0.13
Other digestive organs	1,350	0.11
Nose, nasal cavity, and middle ear	1,500	0.13
Larynx	8,447	0.72
Lung and bronchus	185,853	15.79
Pleura	84	0.01
Trachea, mediastinum, and other respiratory organs	249	0.02
Bones and joints	787	0.07
Soft tissue including heart	4,909	0.42
Melanoma of the skin	28,364	2.41
Other nonepithelial skin	4,253	0.36
Breast	138,041	11.73
Cervix	4,131	0.35
Uterine corpus	27,530	2.34
Uterus NOS	645	0.05
Ovary	16,621	1.41
Vagina	958	0.08
Vulva	3,404	0.29
Other female genital organs	762	0.06
Prostate	221,389	18.81
Testis	206	0.02
Penis	869	0.07
Other male genital organs	259	0.02
Urinary bladder	63,951	5.43
Kidney and renal pelvis	25,484	2.17
Ureter	1,533	0.13
Other urinary organs	770	0.07
Eye and orbit	1,537	0.13
Brain	9,860	0.84
Cranial nerves and other nervous system	461	0.04
Thyroid	6,082	0.52
Other endocrine including thymus	756	0.06
Hodgkin lymphoma—nodal	1,902	0.16
Hodgkin lymphoma—extranodal	87	0.01
Non-Hodgkin lymphoma—nodal	31,191	2.65
Non-Hodgkin lymphoma—extranodal	14,684	1.25
Myeloma	15,993	1.36
Acute lymphocytic leukemia	758	0.06
Chronic lymphocytic leukemia	11,757	1.00
Other lymphocytic leukemia	919	0.08
Acute myeloid leukemia	8,786	0.75
Acute monocytic leukemia	538	0.05
Chronic myeloid leukemia	3,788	0.32
Other myeloid/monocytic leukemia	445	0.04
Other acute leukemia	1,228	0.10
Aleukemic, subleukemic, and NOS leukemia	985	0.08
Mesothelioma	3,460	0.29
Kaposi sarcoma	684	0.06
Miscellaneous	43,061	3.66
Invalid	22	0.00
Total	1,176,950	100.00

Abbreviations: NOS, not otherwise specified; SEER, Surveillance Epidemiology, and End Results.

^aCases were individuals reported to SEER with a first invasive cancer at ages 66–99 years during calendar years 1992–2005, excluding cancers diagnosed at autopsy or by death certificate, and had a minimum of 13 months of Part A, Part B, non-health maintenance organization Medicare coverage preceding cancer diagnosis.

^bCases were classified by using the “SEER site recode with Kaposi sarcoma and mesothelioma.” Refer to http://seer.cancer.gov/siterecode/icdo3_d01272003/ for details.